PepGen (PEPG) News Today $4.25 -0.15 (-3.41%) (As of 10:45 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period PepGen (NASDAQ:PEPG) Given New $6.00 Price Target at Bank of AmericaNovember 20 at 2:51 AM | americanbankingnews.comPepGen price target lowered to $6 from $10 at BofANovember 18 at 8:37 PM | markets.businessinsider.comPepGen (NASDAQ:PEPG) Price Target Cut to $6.00 by Analysts at Bank of AmericaBank of America reduced their target price on PepGen from $10.00 to $6.00 and set a "neutral" rating on the stock in a report on Monday.November 18 at 8:11 AM | marketbeat.comFY2024 EPS Estimates for PepGen Boosted by Leerink PartnrsPepGen Inc. (NASDAQ:PEPG - Free Report) - Research analysts at Leerink Partnrs upped their FY2024 earnings per share (EPS) estimates for PepGen in a note issued to investors on Sunday, November 10th. Leerink Partnrs analyst J. Schwartz now expects that the company will earn ($2.91) per share forNovember 13, 2024 | marketbeat.comPepGen Inc. Receives ‘Buy’ Rating Amid Promising Genetic Medicine Advances and Undervalued Stock PositionNovember 13, 2024 | markets.businessinsider.comPepGen Inc. (PEPG) Receives a Buy from Stifel NicolausNovember 11, 2024 | markets.businessinsider.comNewpark Resources Reports Q3 2024 Financial ResultsNovember 9, 2024 | markets.businessinsider.comPepGen (NASDAQ:PEPG) Price Target Cut to $12.00 by Analysts at WedbushWedbush dropped their target price on shares of PepGen from $19.00 to $12.00 and set an "outperform" rating for the company in a report on Friday.November 8, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for PepGen (NASDAQ:PEPG)HC Wainwright reissued a "buy" rating and issued a $26.00 price objective on shares of PepGen in a research report on Friday.November 8, 2024 | marketbeat.comPepGen Announces Presentations at the 29th Annual Congress of the World Muscle SocietyOctober 8, 2024 | finance.yahoo.comPepGen (NASDAQ:PEPG) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comCapricor Therapeutics Is Up Over 100%, Could Rise Even Higher (PEPG)Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathySeptember 30, 2024 | marketbeat.comPepGen director Christopher Ashton to retire at month's endSeptember 21, 2024 | uk.investing.comPepGen Announces Christopher Ashton, PhD, to Retire from its Board of DirectorsSeptember 19, 2024 | finance.yahoo.comPepGen Announces Christopher Ashton, PhD, to Retire from its Board of DirectorsSeptember 19, 2024 | businesswire.comSofinnova Investments Inc. Raises Stake in PepGen Inc. (NASDAQ:PEPG)Sofinnova Investments Inc. grew its holdings in PepGen Inc. (NASDAQ:PEPG - Free Report) by 11.4% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 561,128 shares of the company's stock after buying an additional 57,504 shares during the period. Sofinnova InSeptember 17, 2024 | marketbeat.comThe Schall Law Firm Is Looking Into PepGen Inc. For Possible Securities Law Infractions And Investors Are Invited To Lend A HandSeptember 11, 2024 | stockhouse.comPepGen (NASDAQ:PEPG) Stock Price Down 0.4%PepGen (NASDAQ:PEPG) Trading Down 0.4%September 5, 2024 | marketbeat.comPepGen Inc Is Being Investigated For Securities Law Infractions And The Schall Law Firm Is Looking For Shareholders To ParticipateAugust 25, 2024 | stockhouse.comPepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & DevelopmentAugust 21, 2024 | finance.yahoo.comPepGen Appoints Paul Streck, M.D., MBA, as Executive Vice President, Head of Research & DevelopmentAugust 20, 2024 | finance.yahoo.comIs PepGen Inc. (NASDAQ:PEPG) Trading At A 34% Discount?August 17, 2024 | finance.yahoo.comVanguard Group Inc. Purchases 344,266 Shares of PepGen Inc. (NASDAQ:PEPG)Vanguard Group Inc. raised its position in shares of PepGen Inc. (NASDAQ:PEPG - Free Report) by 68.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 850,445 shares of the company's stock after acquiring an additioAugust 14, 2024 | marketbeat.comPepGen Inc. (PEPG)August 13, 2024 | uk.finance.yahoo.comPepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAugust 13, 2024 | globenewswire.comFY2027 Earnings Estimate for PepGen Inc. (NASDAQ:PEPG) Issued By HC WainwrightPepGen Inc. (NASDAQ:PEPG - Free Report) - Analysts at HC Wainwright reduced their FY2027 earnings estimates for PepGen in a research note issued to investors on Friday, August 9th. HC Wainwright analyst A. Fein now expects that the company will earn $0.04 per share for the year, down from their pAugust 12, 2024 | marketbeat.comPEPG Stock Earnings: PepGen Misses EPS for Q2 2024August 9, 2024 | markets.businessinsider.comPepGen Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsAugust 8, 2024 | finance.yahoo.comPepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsAugust 7, 2024 | globenewswire.comBuy Rating Affirmed for PepGen Inc. as PGN-EDO51 Shows Promise in DMD Treatment LandscapeAugust 1, 2024 | markets.businessinsider.comOptimistic Outlook on PepGen’s DMD Therapy Despite Initial Data: Analyst Reiterates Buy RatingAugust 1, 2024 | markets.businessinsider.comJanus Henderson Group PLC Purchases 178,438 Shares of PepGen Inc. (NASDAQ:PEPG)Janus Henderson Group PLC lifted its position in PepGen Inc. (NASDAQ:PEPG - Free Report) by 18.1% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 1,166,642 shares of the company's stock after purchasing an additional 178,438 shares during the period. JanAugust 1, 2024 | marketbeat.comPepGen (NASDAQ:PEPG) Stock Rating Reaffirmed by HC WainwrightHC Wainwright restated a "buy" rating and set a $26.00 price objective on shares of PepGen in a research report on Thursday.August 1, 2024 | marketbeat.comPEPG Investors Have Opportunity to Join PepGen Inc. Securities Fraud Investigation with the Schall Law FirmJuly 31, 2024 | tmcnet.comPepGen reports positive data from Phase II Duchenne muscular dystrophy trialJuly 31, 2024 | finance.yahoo.comPepGen: EDOs Could Enhance Dystrophin Expression Beyond Scope Of Current TreatmentsJuly 31, 2024 | seekingalpha.comPepGen (NASDAQ:PEPG) Receives "Outperform" Rating from WedbushWedbush reiterated an "outperform" rating and set a $20.00 price objective on shares of PepGen in a report on Wednesday.July 31, 2024 | marketbeat.comBank of America Lowers PepGen (NASDAQ:PEPG) to NeutralBank of America cut shares of PepGen from a "buy" rating to a "neutral" rating and set a $12.00 target price on the stock. in a research note on Wednesday.July 31, 2024 | marketbeat.comPepGen (NASDAQ:PEPG) Stock Price Down 7.2% Following Insider SellingPepGen (NASDAQ:PEPG) Trading Down 7.2% on Insider SellingJuly 29, 2024 | marketbeat.comMichelle L. Mellion Sells 7,571 Shares of PepGen Inc. (NASDAQ:PEPG) StockJuly 28, 2024 | insidertrades.comPepGen (NASDAQ:PEPG) Reaches New 12-Month High at $18.90PepGen (NASDAQ:PEPG) Sets New 12-Month High at $18.90July 26, 2024 | marketbeat.comPepGen's chief medical officer sells shares worth over $229kJuly 21, 2024 | investing.comPepGen Inc. (NASDAQ:PEPG) Insider Michelle L. Mellion Sells 12,625 SharesJuly 20, 2024 | insidertrades.comPepGen Inc. (NASDAQ:PEPG) Insider Sells $59,315.52 in StockJuly 19, 2024 | insidertrades.comPepGen Inc. (NASDAQ:PEPG) Insider Sells $106,218.00 in StockPepGen Inc. (NASDAQ:PEPG - Get Free Report) insider Michelle L. Mellion sold 5,901 shares of the business's stock in a transaction on Tuesday, July 16th. The shares were sold at an average price of $18.00, for a total value of $106,218.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.July 16, 2024 | marketbeat.comPepGen (NASDAQ:PEPG) Shares Up 3.6%PepGen (NASDAQ:PEPG) Stock Price Up 3.6%July 9, 2024 | marketbeat.comPepGen (NASDAQ:PEPG) Sees Large Volume IncreasePepGen (NASDAQ:PEPG) Sees Unusually-High Trading VolumeJune 28, 2024 | marketbeat.comInsider Selling: PepGen Inc. (NASDAQ:PEPG) Insider Sells 9,260 Shares of StockJune 27, 2024 | insidertrades.comPepGen Inc. (NASDAQ:PEPG) Insider Sells $168,439.40 in StockPepGen Inc. (NASDAQ:PEPG - Get Free Report) insider Michelle L. Mellion sold 9,260 shares of the stock in a transaction on Monday, June 24th. The shares were sold at an average price of $18.19, for a total value of $168,439.40. The sale was disclosed in a filing with the SEC, which is available through the SEC website.June 26, 2024 | marketbeat.comPepGen (NASDAQ:PEPG) Reaches New 12-Month High at $18.72PepGen (NASDAQ:PEPG) Reaches New 12-Month High at $18.72June 24, 2024 | marketbeat.com Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in… >> YES! Send Me My FREE Gold Guide! PEPG Media Mentions By Week PEPG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PEPG News Sentiment▼0.360.47▲Average Medical News Sentiment PEPG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PEPG Articles This Week▼52▲PEPG Articles Average Week Get PepGen News Delivered to You Automatically Sign up to receive the latest news and ratings for PEPG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABIVAX Société Anonyme News IGM Biosciences News MBX Biosciences News Organogenesis News Astria Therapeutics News PureTech Health News Corvus Pharmaceuticals News Mereo BioPharma Group News Pharming Group News Emergent BioSolutions News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PEPG) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PepGen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PepGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
